Finance
Eligen technology company provides second quarter update, including collaboration news
Published in TB and Outbreaks Week, September 9th, 2003
The company also provided an update on development programs involving its proprietary eligen oral drug delivery technology.
"Most notably in the second quarter, we executed on our key strategic objective of creating improved dosage forms of our lead product candidates," commented Michael M. Goldberg, MD, chairman and CEO of Emisphere. "During the second quarter we created enhanced dosage forms of both insulin or heparin and synthesized clinical supplies in our newly validated manufacturing facility."
He continued: "We also...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Immunology
NF-kappaB plays role in gammaherpesvirus latency - Pneumonia
Intervention decreases childhood mortality - Food-borne Disease
Vibrio parahaemolyticus from North America and Asia characterized - Infectious Disease Therapy
Novel triterpenoid active against bacterial and viral pathogens and malignant cells - Malaria Pathogenesis
Novel plasmodial protein plays key role in ookinete differentiation in mosquitos - West Nile Virus
Promising vaccine protects monkeys - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
